TY - JOUR T1 - Impact of Bilateral Transmuscular Quadratus Lumborum Block Using Different Doses of Dexmedetomidine as an Adjuvant Combined with Ropivacaine for Postoperative Analgesia in Laparoscopic Myomectomy JF - medRxiv DO - 10.1101/2020.08.19.20177725 SP - 2020.08.19.20177725 AU - Yue Li AU - Le Zhang AU - Jing Jiao AU - Xinhua Yu AU - Shaoqiang Huang Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/08/22/2020.08.19.20177725.abstract N2 - Introduction The optimal dosage of dexmedetomidine (DEX) as an adjuvant combined with ropivacaine for postoperative analgesia in laparoscopic myomectomy is still controversial. The main aim of this prospective clinical trial was to evaluate the analgesic effect and relevant adverse effects of different doses of dexmedetomidine applied locally for ropivacaine-induced bilateral transmuscular quadratus lumborum block (TQLB).Methods TQLB was conducted using different doses of dexmedetomidine per side (R group: control group; DEX1 group: 0.1μg/kg; DEX2 group: 0.3μg/kg; DEX3 group: 0.5μg/kg). Numeric rating scales (NRS) of pain score, heart rate (HR) and blood pressure (BP) were assessed at different time points after performing TQLB. Dosage of additional analgesics via patient-controlled analgesia pump, recovery time for anal exsufflation, hospital stay and clinical events such as nausea, vomiting and pruritus were also compared among groups.Results A total of 200 patients underwent laparoscopic myomectomy were enrolled in this study and divided into 4 groups (R, DEX1, DEX2 and DEX3 group) randomly, 50 for each group. Compared with R group, NRS pain score was significantly lower in DEX2 group and DEX3group (p<0.001) 10 minutes after TQLB. Twenty minutes after TQLB, statistical significance of NRS pain score appeared between DEX1 group and R group (p<0.05) and between DEX2, 3 group and DEX1 group (p<0.001). In comparison to R group and DEX1 group, NRS pain score in DEX2 and DEX3 group were lower within 24 hours postoperatively (p<0.05). HR in DEX2 group and DEX3 group was significantly lower than DEX1 group and R group (p<0.05). 2 patients in DEX2 and DEX3 group were developed severe low HR of which HR was below 50bpm. Even 6 hours after surgery, patients in DEX3 group still remained severe low HR. Patients in DEX2 group and DEX3 group needed fewer PCA bolus deliveries than patients in R group and DEX1 group (p<0.001). Satisfaction score of postoperative analgesia was higher in DEX2 group and DEX3 group in comparison to DEX1 group and R group (p<0.001).group and DEX3 group in comparison to DEX1 group and R group (p<0.001).Conclusion 0.3μg/kg per side of dexmedetomidine as an adjuvant for TQLB was recommended to effectively relieve postoperative pain after laparoscopic myomectomy.Trial registration Chinese Clinical Trial Registry with registration number ChiCTR1900028509. Date of registration: 24 November 2019. http://www.chictr.org.cn/edit.aspx?pid=42635=htm=4Competing Interest StatementThe authors have declared no competing interest.Clinical TrialChiCTR1900028509Funding StatementNo fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was given by the institutional ethics committee (IRB of Obstetric and Gynecology Hospital of Fudan University) and registered at Chinese Clinical Trial Registry with registration number ChiCTR1900028509. Written informed consent of participation is obtained from all participants. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.(TQLB)transmuscular quadratus lumborum block(NRS)Numeric rating scales(DEX)dexmedetomidine(ERAS)Enhanced Recovery after Surgery(TAP)transversus abdominis plane(PONV)postoperative nausea and vomiting(PACU)postanesthesia care unit(ASA)American Standards Association(TCI)Target controll infusion(PACU)Postanesthesia care unit(HR)Heart rate(BP)Blood pressure(SD)Standard deviation(IQR)Interquartile range ER -